Skip to main content

Specialty Pharmacy

  • Roxane announces telmisartan tablets

    COLUMBUS, OH — Roxane Labs announced the launch of telmisartan tablets USP. The product is available in unit dose packages of 30 tablets.

    Roxane Labs' telmisartan is the authorized generic of Micardis tablets from Boehringer Ingelheim. The product, which used to treat high blood pressure, is available for immediate shipment to wholesalers and pharmacies nationwide.

     

  • Hamacher Resource Group to hold workshop again in March

    WAUKESHA, Wis. — Hamacher Resource Group has announced that is offering its workshop, How to Grow Sales Within Independent Pharmacy, again on March 6 at its headquarters in Waukesha, Wis.

  • Walgreens Infusion Services selected as preferred provider for Makena

    DEERFIELD, Ill. — Walgreens Infusion Services on Monday announced that it has been selected as the preferred provider of home administration services for Makena (hydroxyprogesterone caproate injection), the only FDA-approved medication to help reduce the risk of preterm birth for clinically indicated patients. Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth.

  • ScriptCycle expands solutions for retail pharmacies

    ASHEVILLE, N.C. — ScriptCycle, a technology company that serves pharmacies and patients, will launch its comprehensive cash solutions for retail pharmacies at the NACDS Regional Conference in February. The products aim to help pharmacies address challenges related to their cash prescription business, the company said.

    ScriptCycle said its business model has produced average per-store savings of $7,000 to $12,000 per year.

  • Univ. of Rhode Island pharmacy professor awarded $1.3M grant for cancer research

    KINGSTON, R.I. — The National Institutes of Health have awarded a University of Rhode Island pharmacy professor a $1.3 million grant to further study a new class of inorganic nanoparticles that target primary cancer and help control the disease’s spread and recurrence.



  • Walmart's Agwunobi talks health care, clinics and Obamacare

    ROGERS, Ark. — Walmart health-and-wellness president John Agwunobi shared wide-ranging thoughts regarding the state of health care in America and ways in which the evolving marketplace is impacting Walmart customers.
     

  • Study: Potential therapeutic role for aspirin in inhibiting cancerous vestibular schwannoma growth

    BOSTON — Researchers from Massachusetts Eye and Ear, Harvard Medical School, Massachusetts Institute of Technology and Massachusetts General Hospital have demonstrated that aspirin intake correlates with halted growth of vestibular schwannomas, also known as acoustic neuromas, a sometimes lethal intracranial tumor that typically causes hearing loss and tinnitus.

  • Perrigo approved for generic Prandin

    DUBLIN — Perrigo Co. announced that it received final approval from the Food and Drug Administration for repaglinide tablets — a generic version of Prandin tablets — in 1-mg and 2-mg strengths. The company has started shipment of the drug. Perrigo previously launched the 0.5-mg strength in 2013.

X
This ad will auto-close in 10 seconds